Sara Secall

Partner & Life Sciences Investment Director, Inveready Asset Management

Sara is responsible for building a portfolio of exciting biomedical and health companies at Inveready. She has launched and financed over 25 technology-based companies, and successfully exited several projects with strong VC returns. Since 2001, she has worked in venture capital both in Silicon Valley and in Spain, with technology transfer offices at various universities, and served as an independent expert for the European Commission. She has also consulted in environmental sciences for both Dames and Moore (now URS Corp), the International Finance Corporation, and the World Bank in the US, Canada and Latin America.

Sara received her MBA at London Business School, and holds a Master in Sciences from Indiana University Bloomington and a Bachelor of Science in Chemistry from the Universitat de Barcelona.

Sara Secall v1
Amacathera Logo

AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer and other hard‑to‑reach target areas.

Contact Us

MaRS Centre, West Tower,
661 University Ave Suite 1300,
Toronto, ON M5G 0B7

[email protected]